Blood Test for Insulin Resistance May Help Predict Early Alzheimer's Cognitive Decline
A simple blood test measuring insulin resistance using the TyG index may predict the rate of cognitive decline in early Alzheimer's disease, opening new possibilities for early intervention and personalized treatment.
Read moreStay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Recent Articles
Summer Heatwaves Elevate Risk of Child Fatalities in Hot Vehicles
Rising summer heatwaves are significantly increasing the risk of child fatalities in hot vehicles, emphasizing the need for awareness and preventive routines to save lives.
Michigan Reports Second Measles Outbreak Amid Rising National Cases
Michigan reports its second measles outbreak of 2025 as the US reaches over 1,200 cases nationwide. The resurgence highlights the importance of vaccination to prevent severe complications and curb outbreaks.
France Implements Ban on Smoking in Beaches, Parks, and Bus Shelters to Protect Public Health
France has implemented a nationwide ban on smoking in beaches, parks, and bus shelters to protect children and promote public health. The regulation aims to reduce passive smoking exposure in outdoor public spaces, emphasizing France's commitment to combating tobacco-related health issues.
Gene Therapy Shows Promise in Lowering Stroke Risks for Sickle Cell Patients
Recent research highlights gene therapy's potential to lower stroke risks in sickle cell disease by normalizing brain blood flow, offering new hope for neurovascular health management.
Innovative AI Tool Identifies Nine Types of Dementia Using a Single Brain Scan
Mayo Clinic has developed an AI system, StateViewer, capable of identifying nine different dementia types from a single brain scan, enhancing early diagnosis and treatment planning.
Trust in Sunscreen Brands and the Need for Scrutiny: Lessons from the SPF Controversy
Recent testing reveals that many sunscreens do not meet their labeled SPF claims, shaking consumer trust and highlighting the need for greater transparency and accountability in health product regulation.
Impact of Early 20th Century Medical School Closures on Mortality Rates in the US
Discover how early 20th-century closures of US medical schools, driven by reforms like the Flexner Report, led to significant declines in mortality rates and improved public health outcomes.
Promising Chemoimmunotherapy Approach for Aggressive Stage III Non-Small Cell Lung Cancer
A groundbreaking study suggests that combining chemotherapy with immunotherapy before surgery may improve outcomes for patients with aggressive stage III non-small cell lung cancer, potentially converting unresectable tumors into operable ones.
Insufficient Evidence for Neurosteroid Drugs in Managing Postnatal Depression
Current studies do not conclusively support the use of new neurosteroid drugs like Zuranolone, Brexanolone, and Ganaxolone for postnatal depression. Further research is needed before they can be recommended in clinical practice.
Urine-based Tumor DNA Testing Enhances Personalization of Bladder Cancer Treatment
A new urine-based tumor DNA test shows promise in predicting treatment response and recurrence risk in bladder cancer, enabling more personalized and less invasive management strategies.